James E Flynn Insider Trading $NTMD NITROMED INC
Get free email notifications about insider trading for James E Flynn.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Flynn. James E Flynn is 10% Owner in CAS MEDICAL SYSTEMS INC ($CAMY.OB) and 10% Owner in AxoGen, Inc. ($LECT) and 10% Owner in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and 10% Owner in Fibrocell Science, Inc. ($FCSC) and 10% Owner in STREAMLINE HEALTH SOLUTIONS INC. ($LANV) and 10% Owner in ANTARES PHARMA, INC. ($ATRS) and 10% Owner in VIA Pharmaceuticals, Inc. ($CAQ) and 10% Owner in DUSA PHARMACEUTICALS INC ($DUSA) and 10% Owner in HI TECH PHARMACAL CO INC ($HITK) and 10% Owner in AVADEL PHARMACEUTICALS PLC ($AVDL) and 10% Owner in INSPIRE PHARMACEUTICALS INC ($ISPH) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARENA PHARMACEUTICALS INC ($ARNA) and 10% Owner in ISTA PHARMACEUTICALS INC ($ISTA) and 10% Owner in MEDICINES CO /DE ($MDCO) and 10% Owner in THIRD WAVE TECHNOLOGIES INC /WI ($TWTI) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in Cyclacel Pharmaceuticals, Inc. ($CYCC) and Director in Talon Therapeutics, Inc. ($EMLR) and 10% Owner in LUMOS PHARMA, INC. ($NLNK) and 10% Owner in NITROMED INC ($NTMD) and 10% Owner in XENOPORT INC ($XNPT) and 10% Owner in EMAGEON INC ($EMAG) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in NeuroMetrix, Inc. ($NURO) and 10% Owner in NxStage Medical, Inc. ($NXTM) and 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Vanda Pharmaceuticals Inc. ($VNDA) and 10% Owner in XERIS PHARMACEUTICALS INC ($XERS) and Director in PROTEON THERAPEUTICS INC ($PRTO) and 10% Owner in eHealth, Inc. ($EHTH) and 10% Owner in ZAFGEN, INC. ($ZFGN) and 10% Owner in NeurogesX Inc ($NGSX) and 10% Owner in Invuity, Inc. ($IVTY) and 10% Owner in Dicerna Pharmaceuticals Inc ($DRNA) and 10% Owner in CONSTELLATION PHARMACEUTICALS INC ($CNST) and 10% Owner in TriVascular Technologies, Inc. ($TRIV) and 10% Owner in Auspex Pharmaceuticals, Inc. ($ASPX) and 10% Owner in Neos Therapeutics, Inc. ($NEOS) and 10% Owner in Schrodinger, Inc. ($SDGR) and 10% Owner in CytomX Therapeutics, Inc. ($CTMX) and Director in Acutus Medical, Inc. ($AFIB) and 10% Owner in Annexon, Inc. ($ANNX) and 10% Owner in Aclaris Therapeutics, Inc. ($ACRS) and 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and 10% Owner in Mallinckrodt plc ($MNK) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adverum Biotechnologies, Inc. ($AAVL) and 10% Owner in REGENXBIO Inc. ($RGNX) and 10% Owner in Recro Pharma, Inc. ($REPH) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and Director in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Audentes Therapeutics, Inc. ($BOLD) and 10% Owner in SteadyMed Ltd. ($STDY) and 10% Owner in ShockWave Medical, Inc. ($SWAV) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Editas Medicine, Inc. ($EDIT) and Director in AveXis, Inc. ($AVXS) and 10% Owner in ARVINAS INC. ($ARVN) and 10% Owner in Homology Medicines, Inc. ($FIXX) and Director in Homology Medicines, Inc. ($FIXX) and Director in Oncorus, Inc. ($ONCR) and 10% Owner in Revolution Medicines, Inc. ($RVMD) and 10% Owner in Black Diamond Therapeutics, Inc. ($BDTX) and 10% Owner in Frequency Therapeutics, Inc. ($FREQ) and Director in DFB Healthcare Acquisitions Corp. ($DFBH) and 10% Owner in Generation Bio Co. ($GBIO) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Cabaletta Bio, Inc. ($CABA) and 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and Director in DFP HEALTHCARE ACQUISITIONS CORP. ($DFPH) and Director in Deerfield Healthcare Technology Acquisitions Corp. ($DFHT) and 10% Owner in Terns Pharmaceuticals, Inc. ($TERN).
James E Flynn in NITROMED INC
Trading Symbol: NTMDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James E Flynn: 10% Owner
Holdings: 46,085,133 shares
Latest Transaction: Apr 27 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James E Flynn in NITROMED INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, AFIB, DFBH, ADVM, ALIM, ALPN, ANNX, ATRS, ARNA, ARVN, LIFE, BOLD, ASPX, AVDL, AVXS, LECT, BDTX, CABA, CAMY.OB, CBIO, CNST, CYCC, CTMX, DFHTW, DFPHU, DRNA, DUSA, DVAX, EWTX, EDIT, EHTH, EMAG, FCSC, FREQ, GBIO, HITK, FIXX, ISPH, IVTY, ISTA, KNSA, LRMR, LOXO, NLNK, MNK, MDCO, MIRM, NEOS, NGSX, NURO, NTMD, NKTX, NXTM, ONCR, PRX, TARA, REPH, RGNX, RVMD, RYTM, RIGL, SDGR, SWAV, STDY, LANV, SYRS, EMLR, TERN, TWTI, TRIV, VNDA, CAQ, HOWL, XNPT, XERS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 27 2009 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.86 | 46,085,133 | 39,564,087 | 46,085,133 | 0 to 46.1 M |
Apr 27 2009 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | J | 0.86 | 3,281,497 | 2,817,165 | 0 | 3.3 M to 0 (-100.00 %) |
Apr 27 2009 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | J | 0.86 | 1,783,019 | 1,530,722 | 0 | 1.8 M to 0 (-100.00 %) |
Dec 24 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | S | 0.52 | 7,081 | 3,682 | 3,281,497 | 3.3 M to 3.3 M (-0.22 %) |
Dec 24 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | S | 0.52 | 3,846 | 2,000 | 1,783,017 | 1.8 M to 1.8 M (-0.22 %) |
Dec 24 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | S | 0.56 | 291,512 | 163,247 | 3,288,578 | 3.6 M to 3.3 M (-8.14 %) |
Dec 24 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Sell | S | 0.56 | 158,392 | 88,700 | 1,786,863 | 1.9 M to 1.8 M (-8.14 %) |
Aug 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 1,317 | 1,330 | 3,580,090 | 3.6 M to 3.6 M (+0.04 %) |
Aug 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 718 | 725 | 1,945,255 | 1.9 M to 1.9 M (+0.04 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 6,762 | 6,830 | 3,578,773 | 3.6 M to 3.6 M (+0.19 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 3,688 | 3,725 | 1,944,537 | 1.9 M to 1.9 M (+0.19 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 7,118 | 7,189 | 3,572,011 | 3.6 M to 3.6 M (+0.20 %) |
Aug 01 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 3,882 | 3,921 | 1,940,849 | 1.9 M to 1.9 M (+0.20 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 635 | 641 | 3,564,893 | 3.6 M to 3.6 M (+0.02 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 345 | 348 | 1,936,967 | 1.9 M to 1.9 M (+0.02 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 32,441 | 32,441 | 3,564,258 | 3.5 M to 3.6 M (+0.92 %) |
Jul 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 17,699 | 17,699 | 1,936,622 | 1.9 M to 1.9 M (+0.92 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 5,791 | 5,936 | 3,531,817 | 3.5 M to 3.5 M (+0.16 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 3,159 | 3,238 | 1,918,923 | 1.9 M to 1.9 M (+0.16 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 12,876 | 12,876 | 3,526,026 | 3.5 M to 3.5 M (+0.37 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 7,024 | 7,024 | 1,915,764 | 1.9 M to 1.9 M (+0.37 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 7,733 | 7,888 | 3,513,150 | 3.5 M to 3.5 M (+0.22 %) |
Jul 25 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 4,219 | 4,303 | 1,908,740 | 1.9 M to 1.9 M (+0.22 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 38,249 | 38,631 | 3,505,417 | 3.5 M to 3.5 M (+1.10 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 20,868 | 21,077 | 1,904,521 | 1.9 M to 1.9 M (+1.11 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 28,222 | 28,786 | 3,467,168 | 3.4 M to 3.5 M (+0.82 %) |
Jul 22 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 15,397 | 15,705 | 1,883,653 | 1.9 M to 1.9 M (+0.82 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.99 | 770 | 762 | 3,438,946 | 3.4 M to 3.4 M (+0.02 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.99 | 420 | 416 | 1,868,256 | 1.9 M to 1.9 M (+0.02 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 272 | 275 | 3,438,176 | 3.4 M to 3.4 M (+0.01 %) |
Jul 17 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 148 | 149 | 1,867,836 | 1.9 M to 1.9 M (+0.01 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 16,137 | 16,460 | 3,437,904 | 3.4 M to 3.4 M (+0.47 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.02 | 8,803 | 8,979 | 1,867,688 | 1.9 M to 1.9 M (+0.47 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.97 | 15,650 | 15,181 | 3,421,767 | 3.4 M to 3.4 M (+0.46 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.97 | 8,538 | 8,282 | 1,858,885 | 1.9 M to 1.9 M (+0.46 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 12,380 | 12,132 | 3,406,117 | 3.4 M to 3.4 M (+0.36 %) |
Jul 15 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 6,754 | 6,619 | 1,850,347 | 1.8 M to 1.9 M (+0.37 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.95 | 22,061 | 20,958 | 3,393,737 | 3.4 M to 3.4 M (+0.65 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.95 | 12,035 | 11,433 | 1,843,593 | 1.8 M to 1.8 M (+0.66 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 5,805 | 5,799 | 3,371,676 | 3.4 M to 3.4 M (+0.17 %) |
Jul 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.00 | 3,165 | 3,162 | 1,831,558 | 1.8 M to 1.8 M (+0.17 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 23,629 | 23,156 | 3,365,871 | 3.3 M to 3.4 M (+0.71 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 12,891 | 12,633 | 1,828,393 | 1.8 M to 1.8 M (+0.71 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 195 | 197 | 3,342,242 | 3.3 M to 3.3 M (+0.01 %) |
Jul 07 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.01 | 105 | 106 | 1,815,502 | 1.8 M to 1.8 M (+0.01 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 25,581 | 25,069 | 3,342,047 | 3.3 M to 3.3 M (+0.77 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 0.98 | 13,894 | 13,616 | 1,815,397 | 1.8 M to 1.8 M (+0.77 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 27,148 | 27,962 | 3,316,466 | 3.3 M to 3.3 M (+0.83 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 14,747 | 15,189 | 1,801,503 | 1.8 M to 1.8 M (+0.83 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 2,151 | 2,216 | 3,289,318 | 3.3 M to 3.3 M (+0.07 %) |
Jun 30 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.03 | 1,167 | 1,202 | 1,786,756 | 1.8 M to 1.8 M (+0.07 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 11,783 | 13,550 | 3,287,167 | 3.3 M to 3.3 M (+0.36 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 6,399 | 7,359 | 1,785,589 | 1.8 M to 1.8 M (+0.36 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 43,079 | 49,541 | 3,275,384 | 3.2 M to 3.3 M (+1.33 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 23,400 | 26,910 | 1,779,190 | 1.8 M to 1.8 M (+1.33 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 14,827 | 17,051 | 3,232,305 | 3.2 M to 3.2 M (+0.46 %) |
May 19 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.15 | 8,053 | 9,261 | 1,755,790 | 1.7 M to 1.8 M (+0.46 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 34,350 | 38,472 | 3,180,899 | 3.1 M to 3.2 M (+1.09 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 18,659 | 20,898 | 1,727,870 | 1.7 M to 1.7 M (+1.09 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.17 | 17,043 | 19,940 | 3,146,549 | 3.1 M to 3.1 M (+0.54 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.17 | 9,257 | 10,831 | 1,709,211 | 1.7 M to 1.7 M (+0.54 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.21 | 29,258 | 35,402 | 3,129,506 | 3.1 M to 3.1 M (+0.94 %) |
May 09 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.21 | 15,891 | 19,228 | 1,699,954 | 1.7 M to 1.7 M (+0.94 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.16 | 16,383 | 19,004 | 3,217,478 | 3.2 M to 3.2 M (+0.51 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.16 | 8,899 | 10,323 | 1,747,737 | 1.7 M to 1.7 M (+0.51 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 8,878 | 9,943 | 3,201,095 | 3.2 M to 3.2 M (+0.28 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.12 | 4,821 | 5,400 | 1,738,838 | 1.7 M to 1.7 M (+0.28 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.14 | 11,318 | 12,903 | 3,192,217 | 3.2 M to 3.2 M (+0.36 %) |
May 14 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.14 | 6,147 | 7,008 | 1,734,017 | 1.7 M to 1.7 M (+0.36 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 48,929 | 61,651 | 3,100,248 | 3.1 M to 3.1 M (+1.60 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 26,578 | 33,488 | 1,684,063 | 1.7 M to 1.7 M (+1.60 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.27 | 45,338 | 57,579 | 3,051,319 | 3 M to 3.1 M (+1.51 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.27 | 24,626 | 31,275 | 1,657,485 | 1.6 M to 1.7 M (+1.51 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 10,757 | 13,554 | 3,005,981 | 3 M to 3 M (+0.36 %) |
May 06 2008 | NTMD | NITROMED INC | Flynn James E | 10% Owner | Buy | P | 1.26 | 5,843 | 7,362 | 1,632,859 | 1.6 M to 1.6 M (+0.36 %) |
Page: 1